基于区块链技术的药品网络销售监管体系构建研究
收稿日期: 2026-02-26
修回日期: 2026-06-15
录用日期: 2026-07-22
网络出版日期: 2026-10-27
基金资助
甘肃省药品监督管理局课题(2025GSMPA023)
Research on the Construction of Supervision System for Online Pharmaceutical Sales Based on Blockchain Technology
Received date: 2026-02-26
Revised date: 2026-06-15
Accepted date: 2026-07-22
Online published: 2026-10-27
药品监管工作关乎人民群众身体健康、社会和谐稳定与经济高质量发展。随着“互联网+医药”模式的快速发展,网络购药已发展为常态化消费模式,药品网络销售监管的重要性与紧迫性日益凸显。本研究对药品网络销售监管现状进行梳理,分析当前该领域监管面临的核心挑战,具体涵盖监管资源配置供给不足、跨部门协同监管机制运行不畅、多元责任主体界定模糊、数据安全与隐私泄露风险并存、技术支撑体系建设相对薄弱等方面。针对上述问题,本研究深入剖析了区块链技术在药品网络销售监管体系中的赋能机制与实施路径,并据此提出了系统化的优化策略,包括构建全流程可追溯体系、推动监管模式创新、筑牢数据安全防护屏障以及保障处方真实合规流转等关键环节。应依托技术赋能,推动构建药品网络销售产业新生态,进而助力形成智慧监管与精准治理的监管新格局。
杨巧能
,
刘延忠
.
基于区块链技术的药品网络销售监管体系构建研究
Pharmaceutical regulation is crucial to public health, social harmony and stability, as well as high-quality economic development. With the rapid advancement of the "Internet + Healthcare" model, online drug purchasing has become a common consumption practice, making the supervision of pharmaceutical online sales increasingly prominent and urgent. This study reviews the current state of pharmaceutical online sales regulation and analyzes key challenges, including insufficient allocation of regulatory resources, ineffective cross-departmental coordination mechanisms, unclear delineation of responsible parties, coexisting risks of data security and privacy breaches, and relatively weak technical support capabilities. Addressing these issues, the study thoroughly examines how blockchain technology can enhance the pharmaceutical online sales regulatory framework and proposes systematic optimization strategies, including establishing a comprehensive traceability system, fostering regulatory innovation, strengthening data security safeguards, and ensuring authentic and compliant prescription processing. Through technological empowerment, this approach aims to foster a new ecosystem for the pharmaceutical online sales industry and establish a paradigm of intelligent regulation and precise governance.
[1] 王茜.当药品加入线上销售,使用安全面临新挑战[EB/OL].(2025-12-11)[2026-01-08].https://www.sxrb.com/content/202512/11/c66834.html.
[2] 马飞.强化监管,社会共治,推动网售药品高质量发展[N].医药经济报,2022-9-19(001).
[3] 刘兰茹,兰恭赞.谈药品的属性和分类[J].中国药事,2008,2(2):9-11.
[4] 刘丽清.我院药品不良反应的特点及影响因素分析[J].中国药物与临床.2021,21(7):151-153.
[5] 傅苏颖.药品网络销售新规施行促进医药电商高质量发展[N].中国证券报,2022-12-01(005).
[6] 黄炳生,吴生齐,张征.我国药品网络销售现存风险及监管对策建议[J].中国药业,2022,31(10):18-21.
[7] 王启飞,程梦丽,张毅,等.区块链技术赋能食药安全监管机制研究—基于“鄂冷链”的案例分析[J].电子政务,2021,(11):92-102.
[8] 王群,李馥娟,王振力,等.区块链原理及关键技术[J].计算机科学与探索,2020,14(10):1621-1643.
[9] 桑凌岳,丁薇丽,周立新.区块链技术在药品智慧监管的应用与思考[J].中国医药导刊,2020,22(9):659-660.
[10] 唐菀晨,强文佳,吴欣然,等.新法律法规背景下我国药品网络销售现状及监管情况分析[J].中国医药导刊,2025,27(8):760-765.
[11] 中华人民共和国商务部.2024年药品流通行业运行统计分析报告[EB/OL].(2025-12-08)[2026-01-08].http://search.mofcom.gov.cn/allSearch/?siteId=0&keyWordType=title&acSuggest.
[12] 国家药品监督管理局.国家药监局综合司公开征求《处方药网络零售合规指南(征求意见稿)》意见[EB/OL].(2025-09-08)[2026-01-08].https://www.nmpa.gov.cn/xxgk/zhqyj/zhqyjyp/20250908164504121.html.
[13] 国家药品监督管理局.国家药监局部署深入开展药品安全专项整治[EB/OL].(2022-01-25)[2026-01-08].https://www.nmpa.gov.cn/yaowem/ypjgyw/zhyw/20220125160947139.html.
[14] 国家药品监督管理局.全国药监系统启动实施药品安全巩固提升行动[EB/OL].(2023-06-20)[2026-01-08].https://www.nmpa.gov.cm/yaowem/ypjgyw/zhyw/20230620161852140.html.
[15] 央视网.国家药监局:2025年我国药品抽检合格率99%以上[EB/OL].(2026-01-06)[2026-01-08].https://news.cctv.com/2026/01/06/ARTIDhKTRYjqWyhjNHqbQd7f260106.shtml.
[16] 央广网.精准打击“神医”广告 三部门联合发布《医疗广告认定指南》[EB/OL].(2025-08-13)[2026-01-08].https://finance.cnr.cn/ycbd/20250813/t20250813_527317009.shtml.
[17] 国家药品监督管理局.国家药监局关于药品信息化追溯体系建设的指导意见[EB/OL].(2018-11-01)[2026-01-08].https://www.nmpa.gov.cn/xxgkfgwj/gzwj/gzwjyp/20181101100801272.html.
[18] 国家药品监督管理局.国家药监局召开药品经营“清源”行动巩固提升工作会[EB/OL].(2025-12-11)[2026-01-08].https://www.nmpa.gov.cn/yaowen/ypjgyw/hyxx/yphyxx/20251211172916112.html.
[19] 国家医疗保障局.中国医保惠民生,积跬步,至长远(八):药品追溯码保障安全[EB/OL].(2025-12-30)[2026-01-08].https://www.nhsa.gov.cn/art/2025/12/30/art_14_19185.html.
[20] 张玉青,张然,侯志翠.药品互联网经营的风险与对策[J].中国质量监管,2022,(2):80-83.
[21] 刘琳.网售处方药的风险识别、研判及应对[J].卫生经济研究,2022,39(4):19-23.
[22] 于金彤.我国药品网络销售监管的行政法问题研究[D].宜昌:三峡大学,2023.
[23] 吴少杰.规范处方药网售“面子”“里子”都得管[N].健康报,2025-09-19(005).
[24] 李梦蝶,石荣丽,沈凯,等.“医+药”模式下的电子处方流转监管研究[J].中国药房,2023,34(14):6-11.
/
| 〈 |
|
〉 |